| Literature DB >> 24597975 |
J M van de Kamp1, A Errami, M Howidi, I Anselm, S Winter, J Phalin-Roque, H Osaka, S J M van Dooren, G M Mancini, S J Steinberg, G S Salomons.
Abstract
The BCAP31 gene is located between SLC6A8, associated with X-linked creatine transporter deficiency, and ABCD1, associated with X-linked adrenoleukodystrophy. Recently, loss-of-function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia. We characterized the break points in eight patients with deletions of SLC6A8, BCAP31 and/or ABCD1 and studied the genotype-phenotype correlations. The phenotype in patients with contiguous gene deletions involving BCAP31 overlaps with the phenotype of isolated BCAP31 deficiency. Only deletions involving both BCAP31 and ABCD1 were associated with hepatic cholestasis and death before 1 year, which might be explained by a synergistic effect. Remarkably, a patient with an isolated deletion at the 3'-end of SLC6A8 had a similar severe phenotype as seen in BCAP31 deficiency but without deafness. This might be caused by the disturbance of a regulatory element between SLC6A8 and BCAP31.Entities:
Keywords: X-linked adrenoleukodystrophy; clinical genetics; creatine transporter deficiency; deletion; intellectual disability; liver disease; metabolic disorders; neurology
Mesh:
Substances:
Year: 2014 PMID: 24597975 DOI: 10.1111/cge.12355
Source DB: PubMed Journal: Clin Genet ISSN: 0009-9163 Impact factor: 4.438